These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 17372141)

  • 1. A double-blind, controlled study of botulinum toxin A in chronic myofascial pain.
    Richards BA; Jensen
    Neurology; 2007 Mar; 68(12):963; author reply 963-4. PubMed ID: 17372141
    [No Abstract]   [Full Text] [Related]  

  • 2. Botulinum toxin a in the treatment of chronic tension-type headache with cervical myofascial trigger points: a randomized, double-blind, placebo-controlled pilot study.
    Harden RN; Cottrill J; Gagnon CM; Smitherman TA; Weinland SR; Tann B; Joseph P; Lee TS; Houle TT
    Headache; 2009 May; 49(5):732-43. PubMed ID: 19178577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of a single botulinum type A toxin complex treatment (Dysport) for the relief of upper back myofascial pain syndrome: results from a randomized double-blind placebo-controlled multicentre study.
    Göbel H; Heinze A; Reichel G; Hefter H; Benecke R;
    Pain; 2006 Nov; 125(1-2):82-8. PubMed ID: 16750294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of botulinum toxin type A for the prophylaxis of episodic migraine headaches: a meta-analysis of randomized, double-blind, placebo-controlled trials.
    Shuhendler AJ; Lee S; Siu M; Ondovcik S; Lam K; Alabdullatif A; Zhang X; Machado M; Einarson TR
    Pharmacotherapy; 2009 Jul; 29(7):784-91. PubMed ID: 19558252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Botulinum toxin in pain therapy].
    Jost WH
    MMW Fortschr Med; 2007 Nov; 149(47):47-8. PubMed ID: 18064816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin A versus bupivacaine trigger point injections for the treatment of myofascial pain syndrome: a randomised double blind crossover study.
    Graboski CL; Gray DS; Burnham RS
    Pain; 2005 Nov; 118(1-2):170-5. PubMed ID: 16202527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are the effects of botulinum toxin injection on myofascial trigger points placebo effects or needling effects?
    Hsieh RL; Lee WC
    Arch Phys Med Rehabil; 2008 Apr; 89(4):792-3; author reply 793. PubMed ID: 18374016
    [No Abstract]   [Full Text] [Related]  

  • 8. Therapeutic use of botulinum toxin type A in treating neck and upper-back pain of myofascial origin: a pilot study.
    Lew HL; Lee EH; Castaneda A; Klima R; Date E
    Arch Phys Med Rehabil; 2008 Jan; 89(1):75-80. PubMed ID: 18164334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The analgesic effect of botulinum-toxin A on postwhiplash neck pain.
    Braker C; Yariv S; Adler R; Badarny S; Eisenberg E
    Clin J Pain; 2008 Jan; 24(1):5-10. PubMed ID: 18180629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind, controlled study of botulinum toxin A in chronic myofascial pain.
    Qerama E; Fuglsang-Frederiksen A; Kasch H; Bach FW; Jensen TS
    Neurology; 2006 Jul; 67(2):241-5. PubMed ID: 16864815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Botulinum toxin type A treatment of upper limb spasticity].
    Wissel M; Wissel J
    Wien Klin Wochenschr; 2001; 113 Suppl 4():16-9. PubMed ID: 15506047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind, randomized, placebo-controlled comparison of botulinum toxin type a injection sites and doses in the prevention of episodic migraine.
    Saper JR; Mathew NT; Loder EW; DeGryse R; VanDenburgh AM;
    Pain Med; 2007 Sep; 8(6):478-85. PubMed ID: 17716321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin for cerebral palsy; where are we now?
    Morton RE; Hankinson J; Nicholson J
    Arch Dis Child; 2004 Dec; 89(12):1133-7. PubMed ID: 15557051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin A improves the quality of life of patients with neurogenic urinary incontinence.
    Schurch B; Denys P; Kozma CM; Reese PR; Slaton T; Barron RL
    Eur Urol; 2007 Sep; 52(3):850-8. PubMed ID: 17467889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin type A (Botox) in the treatment of migraine and other headaches.
    Troost BT
    Expert Rev Neurother; 2004 Jan; 4(1):27-31. PubMed ID: 15853612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial: botulinum toxin for neuropathic pain?
    Torgovnick J; Arsura E; Sethi NK; Hu CJ; Yuan RY; Sheu JJ; Apfel SC
    Neurology; 2010 Jan; 74(1):92; author reply 92-3. PubMed ID: 20038781
    [No Abstract]   [Full Text] [Related]  

  • 17. Injection of botulinum toxin type A (BOTOX) into trigger zone of trigeminal neuralgia as a means to control pain.
    Ngeow WC; Nair R
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Mar; 109(3):e47-50. PubMed ID: 20219585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective study examining remote effects of botulinum toxin a in children with cerebral palsy.
    Crowner BE; Racette BA
    Pediatr Neurol; 2008 Oct; 39(4):253-8. PubMed ID: 18805363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin A for myofascial trigger point injection: a qualitative systematic review.
    Ho KY; Tan KH
    Eur J Pain; 2007 Jul; 11(5):519-27. PubMed ID: 17071119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subacromial impingement syndrome as a consequence of botulinum therapy to the upper trapezii: a case report.
    Abbott Z; Richardson JK
    Arch Phys Med Rehabil; 2007 Jul; 88(7):947-9. PubMed ID: 17601479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.